MicoRNA-214-3p: a key player in CPLX2-mediated inhibition on temozolomide resistance in glioma.

Peng Q, Wang L, Wang S, Wang C, Xue Z

Open source

DOI
10.1080/01616412.2022.2064699
Published
2022 Oct
Container
Neurological research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/01616412.2022.2064699,
  title = {MicoRNA-214-3p: a key player in CPLX2-mediated inhibition on temozolomide resistance in glioma.},
  author = {Peng Q and Wang L and Wang S and Wang C and Xue Z},
  year = {2022},
  journal = {Neurological research},
  doi = {10.1080/01616412.2022.2064699},
  url = {https://doi.org/10.1080/01616412.2022.2064699}
}

RIS

TY  - JOUR
TI  - MicoRNA-214-3p: a key player in CPLX2-mediated inhibition on temozolomide resistance in glioma.
AU  - Peng Q
AU  - Wang L
AU  - Wang S
AU  - Wang C
AU  - Xue Z
PY  - 2022
JO  - Neurological research
DO  - 10.1080/01616412.2022.2064699
UR  - https://doi.org/10.1080/01616412.2022.2064699
ER  - 

APA

Q, P., L, W., S, W., C, W., & Z, X. (2022). MicoRNA-214-3p: a key player in CPLX2-mediated inhibition on temozolomide resistance in glioma.. Neurological research. https://doi.org/10.1080/01616412.2022.2064699

Source records